PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
ASY.PA vs. CORT
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between ASY.PA and CORT is 0.06, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.1

Performance

ASY.PA vs. CORT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Assystem S.A. (ASY.PA) and Corcept Therapeutics Incorporated (CORT). The values are adjusted to include any dividend payments, if applicable.

200.00%300.00%400.00%500.00%OctoberNovemberDecember2025FebruaryMarch
405.30%
361.16%
ASY.PA
CORT

Key characteristics

Sharpe Ratio

ASY.PA:

-0.26

CORT:

2.57

Sortino Ratio

ASY.PA:

-0.11

CORT:

3.18

Omega Ratio

ASY.PA:

0.99

CORT:

1.40

Calmar Ratio

ASY.PA:

-0.25

CORT:

3.64

Martin Ratio

ASY.PA:

-0.46

CORT:

14.73

Ulcer Index

ASY.PA:

22.49%

CORT:

8.48%

Daily Std Dev

ASY.PA:

39.01%

CORT:

48.41%

Max Drawdown

ASY.PA:

-94.84%

CORT:

-94.28%

Current Drawdown

ASY.PA:

-28.70%

CORT:

-26.23%

Fundamentals

Market Cap

ASY.PA:

€597.43M

CORT:

$5.73B

EPS

ASY.PA:

€5.79

CORT:

$1.23

PE Ratio

ASY.PA:

7.21

CORT:

44.15

PEG Ratio

ASY.PA:

0.00

CORT:

0.61

Total Revenue (TTM)

ASY.PA:

€301.30M

CORT:

$675.04M

Gross Profit (TTM)

ASY.PA:

€76.70M

CORT:

$664.16M

EBITDA (TTM)

ASY.PA:

€18.80M

CORT:

$137.53M

Returns By Period

In the year-to-date period, ASY.PA achieves a -12.20% return, which is significantly lower than CORT's 7.76% return. Over the past 10 years, ASY.PA has underperformed CORT with an annualized return of 12.98%, while CORT has yielded a comparatively higher 31.74% annualized return.


ASY.PA

YTD

-12.20%

1M

5.30%

6M

-15.31%

1Y

-8.19%

5Y*

13.38%

10Y*

12.98%

CORT

YTD

7.76%

1M

-18.85%

6M

59.24%

1Y

135.78%

5Y*

36.39%

10Y*

31.74%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

ASY.PA vs. CORT — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ASY.PA
The Risk-Adjusted Performance Rank of ASY.PA is 3535
Overall Rank
The Sharpe Ratio Rank of ASY.PA is 3535
Sharpe Ratio Rank
The Sortino Ratio Rank of ASY.PA is 3232
Sortino Ratio Rank
The Omega Ratio Rank of ASY.PA is 3333
Omega Ratio Rank
The Calmar Ratio Rank of ASY.PA is 3434
Calmar Ratio Rank
The Martin Ratio Rank of ASY.PA is 4040
Martin Ratio Rank

CORT
The Risk-Adjusted Performance Rank of CORT is 9696
Overall Rank
The Sharpe Ratio Rank of CORT is 9797
Sharpe Ratio Rank
The Sortino Ratio Rank of CORT is 9494
Sortino Ratio Rank
The Omega Ratio Rank of CORT is 9292
Omega Ratio Rank
The Calmar Ratio Rank of CORT is 9797
Calmar Ratio Rank
The Martin Ratio Rank of CORT is 9797
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

ASY.PA vs. CORT - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Assystem S.A. (ASY.PA) and Corcept Therapeutics Incorporated (CORT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for ASY.PA, currently valued at -0.45, compared to the broader market-3.00-2.00-1.000.001.002.003.00-0.452.75
The chart of Sortino ratio for ASY.PA, currently valued at -0.40, compared to the broader market-4.00-2.000.002.004.00-0.403.33
The chart of Omega ratio for ASY.PA, currently valued at 0.95, compared to the broader market0.501.001.502.000.951.43
The chart of Calmar ratio for ASY.PA, currently valued at -0.42, compared to the broader market0.001.002.003.004.005.00-0.423.85
The chart of Martin ratio for ASY.PA, currently valued at -0.76, compared to the broader market0.005.0010.0015.0020.00-0.7614.78
ASY.PA
CORT

The current ASY.PA Sharpe Ratio is -0.26, which is lower than the CORT Sharpe Ratio of 2.57. The chart below compares the historical Sharpe Ratios of ASY.PA and CORT, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.004.005.00OctoberNovemberDecember2025FebruaryMarch
-0.45
2.75
ASY.PA
CORT

Dividends

ASY.PA vs. CORT - Dividend Comparison

ASY.PA's dividend yield for the trailing twelve months is around 19.16%, while CORT has not paid dividends to shareholders.


TTM20242023202220212020201920182017201620152014
ASY.PA
Assystem S.A.
19.28%16.82%2.02%2.46%2.67%4.07%3.10%3.70%3.34%3.02%3.12%2.57%
CORT
Corcept Therapeutics Incorporated
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Drawdowns

ASY.PA vs. CORT - Drawdown Comparison

The maximum ASY.PA drawdown since its inception was -94.84%, roughly equal to the maximum CORT drawdown of -94.28%. Use the drawdown chart below to compare losses from any high point for ASY.PA and CORT. For additional features, visit the drawdowns tool.


-40.00%-30.00%-20.00%-10.00%0.00%OctoberNovemberDecember2025FebruaryMarch
-28.96%
-23.38%
ASY.PA
CORT

Volatility

ASY.PA vs. CORT - Volatility Comparison

The current volatility for Assystem S.A. (ASY.PA) is 10.53%, while Corcept Therapeutics Incorporated (CORT) has a volatility of 17.03%. This indicates that ASY.PA experiences smaller price fluctuations and is considered to be less risky than CORT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%15.00%20.00%OctoberNovemberDecember2025FebruaryMarch
10.53%
17.03%
ASY.PA
CORT

Financials

ASY.PA vs. CORT - Financials Comparison

This section allows you to compare key financial metrics between Assystem S.A. and Corcept Therapeutics Incorporated. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Please note, different currencies. ASY.PA values in EUR, CORT values in USD
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab